NEUROENDOCRINE PEPTIDES AND THEIR RECEPTORS REGULATING CORTICOTROPHES
神经内分泌肽及其调节皮质激素的受体
基本信息
- 批准号:6594588
- 负责人:
- 金额:$ 14.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:corticotropin releasing factor endocrine pharmacology gene expression genetic regulatory element genetically modified animals glucocorticoids hormone binding protein hormone receptor hormone regulation /control mechanism immunocytochemistry in situ hybridization laboratory mouse laboratory rabbit laboratory rat molecular cloning neuroendocrine system neuropeptides neuroregulation nucleic acid sequence pituitary gland protein kinase A protein kinase C protein structure function receptor expression transcription factor vasopressins
项目摘要
Description: (Taken directly from the application) Corticotropin Releasing
Factor plays key roles in the modulation of adaptive responses of the
endocrine, central nervous and immune systems to stress. In previous granting
periods, this Project characterized CRF and cloned the first CRF receptor
(CRF-R), a G-protein coupled receptor linked to adenylate cyclase. Evidence
derived from receptor chimeras and mutants points to the importance of the
first extracellular domain of the receptor for initial ligand binding but not
for receptor activation. We propose to characterize binding sites within the
first extracellular domain of the receptor and to explore hypotheses regarding
activation of the receptor by specific N-terminal domains of the peptide
ligand. We will also examine ligand-independent or ligand-dependent persistent
activities that we have observed with wild type receptors or ligand/receptor
chimeras.
Since submission of the last competitive proposal, we and others have
identified receptors derived from a second gene, CRF-R2, which surprisingly had
only modest affinity for CRF, but high affinity for CRF-related peptides from
lower vertebrates, urotensin and sauvagine. A novel CRF-related peptide, which
we named urocortin, was then cloned from rat midbrain and human genomic
libraries; the synthetic replicate has high affinity and can functionally
stimulate both type 1 and 2 CRF receptors in vitro and in vivo. We have
anatomic and immunologic evidence for the existence of additional ligands,
related to urotensin and sauvagine and propose to identify them. The roles of
CRF-R2 and its known and unknown ligand(s) will be explored within the
pituitary where we will focus on paracrine interactions. Finally, we will
extend observations of altered urocortin and CRF-R2 expression in different
satiety states and explore the importance of this receptor and its ligands in
mediating central responses to leptin.
In the context of the Program, progress in this Project should continue to
yield information concerning the molecular nature, regulation and physiologic
roles of ligands and receptors of the CRF family and provide insight regarding
endocrine, metabolic and stress-related diseases.
描述:(直接取自应用程序)促肾上腺皮质激素释放
因子在调节适应性反应中起着关键作用,
内分泌、中枢神经和免疫系统对压力的反应。在过去的授予
1999年,本项目对CRF进行了表征,克隆了第一个CRF受体
(CRF-R),一种与腺苷酸环化酶连接的G蛋白偶联受体。证据
来自受体嵌合体和突变体的研究表明,
受体的第一胞外结构域用于初始配体结合,但不
用于受体激活。我们建议表征结合位点内的
受体的第一个胞外结构域,并探索关于
通过肽的特异性N-末端结构域激活受体
配体。我们还将研究配体非依赖性或配体依赖性的持续性
我们观察到的野生型受体或配体/受体的活性
嵌合体
自提交上一份竞争性投标书以来,我们和其他机构
鉴定了来自第二个基因CRF-R2的受体,令人惊讶的是,
仅对CRF具有中等亲和力,但对CRF相关肽具有高亲和力
低等脊椎动物,尾加压素和sauvagine。一种新的CRF相关肽,
我们命名为urocortin,然后从大鼠中脑和人类基因组中克隆,
库;合成复制具有高亲和力并且可以在功能上
在体外和体内刺激1型和2型CRF受体。我们有
存在其他配体的解剖学和免疫学证据,
与尾加压素和sauvagine有关,并建议鉴定它们。的作用
CRF-R2及其已知和未知配体将在
我们将重点讨论旁分泌的相互作用。最后我们将
在不同组织中尿皮质素和CRF-R2表达改变的扩展观察
饱足状态,并探讨这种受体及其配体在
介导对瘦素的中枢反应。
在该方案的范围内,该项目的进展应继续,
产生关于分子性质、调节和生理的信息,
CRF家族的配体和受体的作用,并提供有关
内分泌、代谢和压力相关疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WYLIE W. VALE其他文献
WYLIE W. VALE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WYLIE W. VALE', 18)}}的其他基金
ROLE OF BETAGLYCAN IN INHIBIN ANTAGONISM OF ACTIVIN
Betaglycan 在激活素抑制素拮抗作用中的作用
- 批准号:
7537246 - 财政年份:2007
- 资助金额:
$ 14.86万 - 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
- 批准号:
6769849 - 财政年份:2004
- 资助金额:
$ 14.86万 - 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
- 批准号:
6898291 - 财政年份:2004
- 资助金额:
$ 14.86万 - 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
- 批准号:
7066615 - 财政年份:2004
- 资助金额:
$ 14.86万 - 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
- 批准号:
7426782 - 财政年份:2004
- 资助金额:
$ 14.86万 - 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
- 批准号:
7236161 - 财政年份:2004
- 资助金额:
$ 14.86万 - 项目类别: